Retractable Technologies (RVP) vs. Its Rivals Head-To-Head Survey

Retractable Technologies (NYSE:RVPGet Rating) is one of 213 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare Retractable Technologies to similar companies based on the strength of its profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Retractable Technologies and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Retractable Technologies 0 0 0 0 N/A
Retractable Technologies Competitors 1268 4585 7987 221 2.51

As a group, “Surgical & medical instruments” companies have a potential upside of 57.72%. Given Retractable Technologies’ peers higher possible upside, analysts clearly believe Retractable Technologies has less favorable growth aspects than its peers.

Profitability

This table compares Retractable Technologies and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Retractable Technologies 29.76% 70.02% 32.11%
Retractable Technologies Competitors -678.57% -64.71% -19.37%

Institutional and Insider Ownership

23.7% of Retractable Technologies shares are owned by institutional investors. Comparatively, 50.7% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 50.4% of Retractable Technologies shares are owned by company insiders. Comparatively, 14.1% of shares of all “Surgical & medical instruments” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Retractable Technologies and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Retractable Technologies $188.38 million $56.06 million 2.27
Retractable Technologies Competitors $1.15 billion $84.54 million -508.57

Retractable Technologies’ peers have higher revenue and earnings than Retractable Technologies. Retractable Technologies is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Risk & Volatility

Retractable Technologies has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Comparatively, Retractable Technologies’ peers have a beta of 1.13, meaning that their average share price is 13% more volatile than the S&P 500.

Summary

Retractable Technologies beats its peers on 6 of the 10 factors compared.

Retractable Technologies Company Profile (Get Rating)

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.